title: [Lozartan potential in hyperuricemia correction].
abstract: Recently, much attention of medical professionals is directed to correlations between hyperuricemia, arterial hypertension, metabolic syndrome and renal affection because of the evidence that elevated blood level of uric acid raises the risk of cardiovascular complications not only in arterial hypertension and metabolic syndrome but also in diabetes mellitus type 2, coronary heart disease, congestive heart failure and renal dysfunction. Administration of uricosuric medication in hyperuricemia and goat has contraindications in some cases. A number of trials show a corrective action of lozartan. Other blockers of receptors to angiotensin II has no such effect.
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D033461:Hyperuricemia / Q000150:complications / Q000188:drug therapy*; D019808:Losartan / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000150:complications / Q000188:drug therapy*; D014527:Uric Acid / Q000097:blood / Q000378:metabolism*
chemical_list: D000959:Antihypertensive Agents; D014527:Uric Acid; D019808:Losartan